• Je něco špatně v tomto záznamu ?

Proteomic and transcriptomic analysis of heart failure due to volume overload in a rat aorto-caval fistula model provides support for new potential therapeutic targets - monoamine oxidase A and transglutaminase 2

Jiri Petrak, Jana Pospisilova, Miroslava Sedinova, Petr Jedelsky, Lucie Lorkova, Ondrej Vit, Michal Kolar, Hynek Strnad, Jan Benes, David Sedmera, Ludek Cervenka, Vojtech Melenovsky

. 2011 ; 9 (1) : 69.

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc13015783

Grantová podpora
NS10497 MZ0 CEP - Centrální evidence projektů
NS10300 MZ0 CEP - Centrální evidence projektů
NT12248 MZ0 CEP - Centrální evidence projektů

BACKGROUND: Chronic hemodynamic overloading leads to heart failure (HF) due to incompletely understood mechanisms. To gain deeper insight into the molecular pathophysiology of volume overload-induced HF and to identify potential markers and targets for novel therapies, we performed proteomic and mRNA expression analysis comparing myocardium from Wistar rats with HF induced by a chronic aorto-caval fistula (ACF) and sham-operated rats harvested at the advanced, decompensated stage of HF. METHODS: We analyzed control and failing myocardium employing iTRAQ labeling, two-dimensional peptide separation combining peptide IEF and nano-HPLC with MALDI-MS/MS. For the transcriptomic analysis we employed Illumina RatRef-12v1 Expression BeadChip. RESULTS: In the proteomic analysis we identified 2030 myocardial proteins, of which 66 proteins were differentially expressed. The mRNA expression analysis identified 851 differentially expressed mRNAs. CONCLUSIONS: The differentially expressed proteins confirm a switch in the substrate preference from fatty acids to other sources in the failing heart. Failing hearts showed downregulation of the major calcium transporters SERCA2 and ryanodine receptor 2 and altered expression of creatine kinases. Decreased expression of two NADPH producing proteins suggests a decreased redox reserve. Overexpression of annexins supports their possible potential as HF biomarkers. Most importantly, among the most up-regulated proteins in ACF hearts were monoamine oxidase A and transglutaminase 2 that are both potential attractive targets of low molecular weight inhibitors in future HF therapy.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc13015783
003      
CZ-PrNML
005      
20181105132839.0
007      
ta
008      
130424s2011 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/1477-5956-9-69 $2 doi
035    __
$a (PubMed)22078724
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Petrák, Jiří $7 ola2006329820 $u Institute of Pathological Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic. jpetr@lf1.cuni.cz.
245    10
$a Proteomic and transcriptomic analysis of heart failure due to volume overload in a rat aorto-caval fistula model provides support for new potential therapeutic targets - monoamine oxidase A and transglutaminase 2 / $c Jiri Petrak, Jana Pospisilova, Miroslava Sedinova, Petr Jedelsky, Lucie Lorkova, Ondrej Vit, Michal Kolar, Hynek Strnad, Jan Benes, David Sedmera, Ludek Cervenka, Vojtech Melenovsky
520    9_
$a BACKGROUND: Chronic hemodynamic overloading leads to heart failure (HF) due to incompletely understood mechanisms. To gain deeper insight into the molecular pathophysiology of volume overload-induced HF and to identify potential markers and targets for novel therapies, we performed proteomic and mRNA expression analysis comparing myocardium from Wistar rats with HF induced by a chronic aorto-caval fistula (ACF) and sham-operated rats harvested at the advanced, decompensated stage of HF. METHODS: We analyzed control and failing myocardium employing iTRAQ labeling, two-dimensional peptide separation combining peptide IEF and nano-HPLC with MALDI-MS/MS. For the transcriptomic analysis we employed Illumina RatRef-12v1 Expression BeadChip. RESULTS: In the proteomic analysis we identified 2030 myocardial proteins, of which 66 proteins were differentially expressed. The mRNA expression analysis identified 851 differentially expressed mRNAs. CONCLUSIONS: The differentially expressed proteins confirm a switch in the substrate preference from fatty acids to other sources in the failing heart. Failing hearts showed downregulation of the major calcium transporters SERCA2 and ryanodine receptor 2 and altered expression of creatine kinases. Decreased expression of two NADPH producing proteins suggests a decreased redox reserve. Overexpression of annexins supports their possible potential as HF biomarkers. Most importantly, among the most up-regulated proteins in ACF hearts were monoamine oxidase A and transglutaminase 2 that are both potential attractive targets of low molecular weight inhibitors in future HF therapy.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Pospíšilová, Jana $u Institute of Pathological Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1#
$a Šedinová, Miroslava. $7 xx0215602 $u Faculty of Science, Charles University, Prague, Czech Republic
700    1_
$a Jedelský, Petr $u Faculty of Science, Charles University, Prague, Czech Republic
700    1_
$a Lorková, Lucie $u Institute of Pathological Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Vit, Ondřej $u Institute of Pathological Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Kolar, Michal $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic
700    1_
$a Strnad, Hynek $7 xx0125779 $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic
700    1_
$a Beneš, Jan, $d 1983- $7 xx0221722 $u Department for Experimental Medicine and Department of Cardiology, Institute for Clinical and Experimental Medicine-IKEM, Prague, Czech Republic
700    1_
$a Sedmera, David, $d 1971- $7 xx0037135 $u Institute of Anatomy, First Faculty of Medicine, Charles University, Prague, Czech Republic; Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic
700    1_
$a Červenka, Luděk $u Department for Experimental Medicine and Department of Cardiology, Institute for Clinical and Experimental Medicine-IKEM, Prague, Czech Republic; Department of Physiology, 2nd Medical Faculty, Charles University, Prague, Czech Republic
700    1_
$a Melenovský, Vojtěch $7 xx0160847 $u Department for Experimental Medicine and Department of Cardiology, Institute for Clinical and Experimental Medicine-IKEM, Prague, Czech Republic
773    0_
$w MED00008250 $t Proteome science $x 1477-5956 $g Roč. 9, č. 1 (2011), s. 69
856    41
$u https://pubmed.ncbi.nlm.nih.gov/22078724 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20130424 $b ABA008
991    __
$a 20181105132913 $b ABA008
999    __
$a ind $b bmc $g 978984 $s 814104
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2011 $b 9 $c 1 $d 69 $i 1477-5956 $m Proteome science $n Proteome Sci $x MED00008250
GRA    __
$a NS10497 $p MZ0
GRA    __
$a NS10300 $p MZ0
GRA    __
$a NT12248 $p MZ0
LZP    __
$a Pubmed-20130424

Najít záznam

Citační ukazatele

Možnosti archivace